160 related articles for article (PubMed ID: 27123271)
41. Current treatment approaches for mantle-cell lymphoma.
Witzig TE
J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
[TBL] [Abstract][Full Text] [Related]
42. Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
William BM; Allen MS; Loberiza FR; Bociek RG; Bierman PJ; Armitage JO; Vose JM
Biol Blood Marrow Transplant; 2014 Apr; 20(4):536-42. PubMed ID: 24434781
[TBL] [Abstract][Full Text] [Related]
43. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY; Abd El-Wahed MM; Dawoud MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
[TBL] [Abstract][Full Text] [Related]
45. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
46. Primary cutaneous blastoid mantle cell lymphoma-case report.
Estrozi B; Sanches JA; Varela PC; Bacchi CE
Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
[TBL] [Abstract][Full Text] [Related]
47. Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features.
Sen F; Medeiros LJ; Lu D; Jones D; Lai R; Katz R; Abruzzo LV
Am J Surg Pathol; 2002 Oct; 26(10):1312-8. PubMed ID: 12360046
[TBL] [Abstract][Full Text] [Related]
48. Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.
Bertz H; Illerhaus G; Veelken H; Finke J
Ann Oncol; 2002 Jan; 13(1):135-9. PubMed ID: 11863095
[TBL] [Abstract][Full Text] [Related]
49. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
50. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
51. Cooccurrence of CD10-Positive and CD10-Negative Mantle Cell Lymphoma Complicated With Central Nervous System Involvement Solely by CD10-Positive Population.
Fukushima N; Mino T; Arihiro K; Ichinohe T
Cureus; 2022 Jan; 14(1):e21341. PubMed ID: 35186599
[TBL] [Abstract][Full Text] [Related]
52. Mantle cell lymphoma involvement of the pleura and tuberculous pleurisy with pulmonary tuberculosis: a case report and literature review.
Anai S; Hashisako M; Ikegame S; Wakamatsu K; Nagata N; Nakanishi Y; Kajiki A
J Infect Chemother; 2012 Apr; 18(2):258-64. PubMed ID: 21968964
[TBL] [Abstract][Full Text] [Related]
53. A case report of mantle cell lymphoma manifesting as a foot lesion.
Samarghandi A; Ahuja S; Gupta S; Fulger I; Katava G; Fang Y
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26797933
[TBL] [Abstract][Full Text] [Related]
54. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
[TBL] [Abstract][Full Text] [Related]
55. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
[TBL] [Abstract][Full Text] [Related]
56. Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse.
Malkan UY; Gunes G; Yayar O; Demiroglu H
Case Rep Med; 2015; 2015():137682. PubMed ID: 26457084
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous lymphocyte-associated antigen (CLA) expression in a lymphoblastoid mantle cell lymphoma presenting with skin lesions. Comparison with other clinicopathologic presentations of mantle cell lymphoma.
Martí RM; Campo E; Bosch F; Palou J; Estrach T
J Cutan Pathol; 2001 May; 28(5):256-64. PubMed ID: 11401669
[TBL] [Abstract][Full Text] [Related]
58. Mantle cell lymphoma diagnosed by conjunctival salmon-pink lesion biopsy.
Matsuo T; Ichimura K; Kubonishi S
J Clin Exp Hematop; 2014; 54(2):143-7. PubMed ID: 25318947
[TBL] [Abstract][Full Text] [Related]
59. Management of Hodgkin's lymphoma with midbrain involvement: A case report and review of literature.
Maka VV; Chitrapur R; Kilara N; Prabhu VM; Krishnamoorthy N
Hematology; 2015 Jun; 20(5):272-5. PubMed ID: 25133862
[TBL] [Abstract][Full Text] [Related]
60. When Snoring isn't just Snoring: Primary Nasopharyngeal Mantle Cell Lymphoma - A Rare Pathology in the Nasopharynx.
Keidar E; Vu QN; Shermetaro C
Spartan Med Res J; 2019 Jul; 4(1):7959. PubMed ID: 33655156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
